Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans

NA Farid, A Kurihara… - The Journal of Clinical …, 2010 - Wiley Online Library
Ticlopidine, clopidogrel, and prasugrel are thienopyridine prodrugs that inhibit adenosine‐5′‐diphosphate
(ADP)‐mediated platelet aggregation in vivo. These compounds are …

Lumbar Spinal Stenosis and Nerve Root Entrapment Syndromes.

…, WH Kirkaldy-Willis, A Kurihara… - … Research (1976-2007 …, 1976 - journals.lww.com
Throughout this Symposium the contributors are concerned with the “bringing together” of
numerous contributions dealing with back and leg pain over the past 75 years. These …

Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite

…, NA Farid, O Okazaki, T Ikeda, A Kurihara - Drug Metabolism and …, 2010 - ASPET
The aim of the current study is to identify the human cytochrome P450 (P450) isoforms
involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically …

Lumbar disc herniation in children and adolescents: a review of 70 operated cases and their minimum 5-year follow-up studies

A Kurihara, O Kataoka - Spine, 1980 - journals.lww.com
Seventy cases of surgically documented herniated lumbar disc in children and adolescents
were analyzed. Twenty-six of the 70 cases were followed at least five years postoperatively. …

Minimum 10-year outcome of decompressive laminectomy for degenerative lumbar spinal stenosis

T Iguchi, A Kurihara, J Nakayama, K Sato, M Kurosaka… - Spine, 2000 - journals.lww.com
Study Design. A retrospective follow-up study was conducted in patients who underwent
decompressive laminectomy for degenerative lumbar spinal stenosis. Objectives. To describe …

[HTML][HTML] The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet …

A Sugidachi, T Ogawa, A Kurihara, K Hagihara… - Journal of Thrombosis …, 2007 - Elsevier
Background and methods: Prasugrel is a novel orally active thienopyridine prodrug with
potent and long‐lasting antiplatelet effects. Platelet inhibition reflects inhibition of P2Y 12 …

[PDF][PDF] On some examples of equations defining Shimura curves and the Mumford uniformization

A Kurihara - J. Fac. Sci. Univ. Tokyo Sect. IA Math, 1979 - repository.dl.itc.u-tokyo.ac.jp
Let F" be a totally real algebraic number field of finite degree, and B a quaternion algebra
over F'such that kk is isomorphic to M,(R) X HX---XH, where H denotes the Hamilton …

Lumbar instability and clinical symptoms: which is the more critical factor for symptoms: sagittal translation or segment angulation?

…, K Kasahara, K Sato, A Kurihara… - Clinical Spine …, 2004 - journals.lww.com
Background: The relationship between radiologic instability and its symptoms is controversial.
Previous authors consider flexion–extension radiographs to be of little value in evaluating …

Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450

…, NA Farid, JB Heim, SC Kasper, A Kurihara… - Drug Metabolism and …, 2006 - ASPET
The biotransformation of prasugrel to R-138727 (2-[1-2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-mercapto-3-piperidinylidene]acetic
acid) involves rapid deesterification to R-95913 (…

Quantitative determination of clopidogrel active metabolite in human plasma by LC–MS/MS

…, H Pang, K Kawabata, NA Farid, A Kurihara - … of pharmaceutical and …, 2008 - Elsevier
A quantitative method for the determination of clopidogrel active metabolite (AM) in human
plasma was developed and validated using liquid chromatography–tandem mass …